TSCAN THERAPEUTICS INC. - COMMON STOCK

1,2400

16-мая-25 16:45:00

15 мин. задержка

Акции

-0,0700

-5,34%

Сегодняшний диапазон

1,2250 - 1,3250

ISIN

N/A

Источник

NASDAQ

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

13 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

09 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

24 апр 2024 16:05:34 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

24 апр 2024 11:03:30 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

22 апр 2024 17:01:23 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Closing of Upsized Public Offering

19 апр 2024 10:05:23 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

17 апр 2024 00:30:57 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

16 апр 2024 16:25:22 Источник Nasdaq GlobeNewswire
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

16 апр 2024 16:01:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

08 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

02 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

06 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

28 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

26 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

14 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

06 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

29 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

18 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress

04 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

09 дек 2023 12:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.